Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2017-09-11 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Genedrive HCV Kit received CE Marking
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 2849Q' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange'. This strongly indicates the document is a regulatory announcement distributed via the London Stock Exchange's Regulatory News Service (RNS). The content itself is an announcement about achieving CE certification for a product, which is a material event but is being disseminated through the RNS channel. Since 'RNS' is the specific category for general regulatory announcements not covered by more specific codes (like 10-K, ER, DIV, etc.), this is the most appropriate classification. The document length (4583 chars) is not extremely short, but the primary identifier is the RNS header/footer.
2017-09-11 English
$1.4m Funding from US Department of Defense
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement. The content announces that 'genedrive plc' has been awarded additional funding from the US Department of Defense for continued development. This is a specific corporate update regarding funding and development progress, not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it is a formal announcement released via the London Stock Exchange's news service (indicated by 'RNS Number' and 'END' marker), and it details a specific corporate event (funding award), it fits best under the general Regulatory Filings category (RNS) as it doesn't precisely match the more specific categories like Capital/Financing Update (CAP) which usually relates to issuing securities or debt, or a Legal Report (LTR). Given the structure and the explicit RNS identifier, RNS is the most appropriate classification.
2017-07-27 English
Trading Update
Earnings Release Classification · 1% confidence The document is identified by the header 'RNS Number : 9183K' and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content is a 'Trading Update' providing unaudited year-end revenue figures (£5.8m vs £5.1m) and cash position updates for the twelve months ended 30 June 2017. This is a preliminary announcement of financial results, not the full annual report (10-K) or a comprehensive interim report (IR). It fits the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). Although it mentions the full results will be reported in October 2017, this specific document serves as the preliminary update. FY 2017
2017-07-13 English
Hep C data presentation at EASL
Report Publication Announcement Classification · 1% confidence The document begins with an 'RNS Number' and is dated April 11, 2017. The content announces that clinical validation data for the Genedrive® HCV ID Kit will be presented at an international conference (EASL). This is a general announcement of company activity, product progress, and upcoming presentation, rather than a formal financial report (like 10-K or IR), a management change (MANG), or a specific regulatory filing like a Director's Dealing (DIRS) or Dividend Notice (DIV). Since it is a general, non-financial, non-management specific announcement distributed via the RNS system, it fits best under the general 'Regulatory Filings' category, which serves as a fallback for miscellaneous regulatory news releases.
2017-04-11 English
Director/PDMR Shareholding - Replacement
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' header and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. This explicitly details share option grants to directors (David Budd, Allan Brown, Gino Miele). This type of insider transaction reporting falls directly under the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2017-04-05 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' header and contains an 'Initial notification' regarding 'transactions by persons discharging managerial responsibilities' (directors/senior management) involving the 'Grant of options'. This structure precisely matches the definition of a Director's Dealing report, which details insider transactions. The filing code corresponding to this activity is DIRS. Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2017-04-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.